S&P Equity Research Reiterates 'Sell' Rating on Neuroncrine Biosciences (NBIX) May 1, 2008 10:33AM
Neurocrine Biosciences (NBIX) Reports In-Line Q1 Loss of $0.55 Apr 30, 2008 04:50PM